JP2023531675A5 - - Google Patents
Info
- Publication number
- JP2023531675A5 JP2023531675A5 JP2022578935A JP2022578935A JP2023531675A5 JP 2023531675 A5 JP2023531675 A5 JP 2023531675A5 JP 2022578935 A JP2022578935 A JP 2022578935A JP 2022578935 A JP2022578935 A JP 2022578935A JP 2023531675 A5 JP2023531675 A5 JP 2023531675A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- berzutifan
- hif
- inhibitor
- pharmaceutically acceptable
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063042307P | 2020-06-22 | 2020-06-22 | |
| US63/042,307 | 2020-06-22 | ||
| US202163146915P | 2021-02-08 | 2021-02-08 | |
| US63/146,915 | 2021-02-08 | ||
| PCT/US2021/038172 WO2021262563A1 (en) | 2020-06-22 | 2021-06-21 | Methods for treating cancer or von-hippel lindau disease using a combination of a hif-2 alpha inhibitor and lenvatinib |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023531675A JP2023531675A (ja) | 2023-07-25 |
| JP2023531675A5 true JP2023531675A5 (https=) | 2024-06-27 |
| JP7750884B2 JP7750884B2 (ja) | 2025-10-07 |
Family
ID=79281740
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022578935A Active JP7750884B2 (ja) | 2020-06-22 | 2021-06-21 | ＨＩＦ－２α阻害剤とレンバチニブの組み合わせを使用して、癌またはフォンヒッペル・リンダウ病を処置するための方法 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20230210838A1 (https=) |
| EP (1) | EP4168008B1 (https=) |
| JP (1) | JP7750884B2 (https=) |
| KR (1) | KR20230026493A (https=) |
| CN (1) | CN115803629A (https=) |
| AU (1) | AU2021296151A1 (https=) |
| BR (1) | BR112022026094A2 (https=) |
| CA (1) | CA3183852A1 (https=) |
| MX (2) | MX2022016406A (https=) |
| WO (1) | WO2021262563A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN115463217B (zh) * | 2021-06-11 | 2024-03-12 | 深圳埃格林医药有限公司 | 己酸羟孕酮在增强肿瘤治疗效果中的应用 |
| CN119731864A (zh) | 2023-02-28 | 2025-03-28 | 株式会社Lg新能源 | 电化学装置用分隔件和包括其的电化学装置 |
| AU2024248799A1 (en) * | 2023-03-31 | 2025-10-23 | Daiichi Sankyo Company, Limited | Combination of anti-CDH6 antibody-drug conjugate and HIF-2alpha inhibitor |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2016168510A1 (en) * | 2015-04-17 | 2016-10-20 | Peloton Therapeutics, Inc. | Combination therapy of a hif-2-alpha inhibitor and an immunotherapeutic agent and uses thereof |
| WO2018031680A1 (en) * | 2016-08-10 | 2018-02-15 | Fronthera U.S. Pharmaceuticals Llc | Novel compounds, uses and methods for their preparation |
| WO2020081695A1 (en) * | 2018-10-17 | 2020-04-23 | Nikang Therapeutics, Inc. | Indane derivatives as hypoxia inducible factor-2(alpha) inhibitors |
-
2021
- 2021-06-21 JP JP2022578935A patent/JP7750884B2/ja active Active
- 2021-06-21 CN CN202180049537.5A patent/CN115803629A/zh active Pending
- 2021-06-21 KR KR1020237002565A patent/KR20230026493A/ko active Pending
- 2021-06-21 AU AU2021296151A patent/AU2021296151A1/en active Pending
- 2021-06-21 CA CA3183852A patent/CA3183852A1/en active Pending
- 2021-06-21 EP EP21828761.3A patent/EP4168008B1/en active Active
- 2021-06-21 BR BR112022026094A patent/BR112022026094A2/pt unknown
- 2021-06-21 MX MX2022016406A patent/MX2022016406A/es unknown
- 2021-06-21 US US18/009,115 patent/US20230210838A1/en active Pending
- 2021-06-21 WO PCT/US2021/038172 patent/WO2021262563A1/en not_active Ceased
-
2022
- 2022-12-16 MX MX2025014865A patent/MX2025014865A/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022191257A5 (https=) | ||
| JP2021063088A5 (https=) | ||
| JP2023002662A5 (https=) | ||
| JP2021098728A5 (https=) | ||
| JP2023531675A5 (https=) | ||
| JP2024540183A5 (https=) | ||
| JP2015523397A5 (https=) | ||
| TWI455723B (zh) | 納曲酮及安非他酮於治療超重或肥胖病患之用途 | |
| JP2015512406A5 (https=) | ||
| JP2020521797A5 (https=) | ||
| EP4520394A3 (en) | New therapeutic combinations for the treatment of progressive fibrosing interstitial lung diseases | |
| JP2013541583A5 (https=) | ||
| JP2021512906A5 (https=) | ||
| JP2019533660A5 (https=) | ||
| JP2015528501A5 (https=) | ||
| JP2021073257A5 (https=) | ||
| JP2024512425A5 (https=) | ||
| JP2021502392A5 (https=) | ||
| JP2023530264A5 (https=) | ||
| JP2023549849A5 (https=) | ||
| JP2015522077A5 (https=) | ||
| JP2024527023A5 (https=) | ||
| JP2023531930A5 (https=) | ||
| WO2017148129A1 (zh) | 一种用于治疗恶病质的药物组合物及其应用 | |
| JP2016505050A5 (https=) |